MiNK Therapeutics, Inc. reports stock transactions
- Jennifer Buell sold 6,938 shares on 10/12/2026
- Buell acquired 23,191 shares on 10/11/2026
- Buell holds 74,195 shares directly
Jennifer Buell, reporting
INKT
MiNK Therapeutics, Inc. SEC filings
Every EDGAR filing for MiNK Therapeutics, Inc. (INKT), newest first, with AI summaries and stories.
- Ticker
- INKT
- CIK
- 1840229
- Latest filing
- 4d
Next: earnings expected ~Nov 16 ยท 10-Q expected ~Nov 16 (deadline Nov 16)
Insider activity
No open-market insider buys in the last 30 days.
Also: 1 open-market sale ($73K), 1 grant or exercise.
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE4MiNK Therapeutics, Inc.INKTLIVE ROUTINE144MiNK Therapeutics, Inc.INKTLIVE MiNK Therapeutics files Form 144
- Filer: Buell Jennifer
- Securities: 6938 shares of common stock
- Date of sale: 10/12/2026
Jennifer Buell, reporting
ROUTINE4MiNK Therapeutics, Inc.INKTLIVE 5 insider filings
Ulf Wiinberg, insider filing for INKT
Show all 5
- 4Insider filing for INKT
- 4Insider filing for INKT
- 4Insider filing for INKT
- 4Insider filing for INKT
- 4Insider filing for INKT
Ulf Wiinberg, reporting
NOTABLE10-QMiNK Therapeutics, Inc.INKTLIVE ROUTINES-8MiNK Therapeutics, Inc.INKTLIVE ROUTINE8-KMiNK Therapeutics, Inc.INKTLIVE ROUTINE8-KMiNK Therapeutics, Inc.INKTLIVE ROUTINE4MiNK Therapeutics, Inc.INKTLIVE Barbara Ryan, insider filing for INKT
Barbara Ryan, reporting
ROUTINE4MiNK Therapeutics, Inc.INKTLIVE 5 insider filings
John Bradley Holcomb, insider filing for INKT
Show all 5
- 4Insider filing for INKT
- 4Insider filing for INKT
- 4Insider filing for INKT
- 4Insider filing for INKT
- 4Insider filing for INKT
John Bradley Holcomb, reporting
NOTABLE10-QMiNK Therapeutics, Inc.INKTLIVE ROUTINE8-KMiNK Therapeutics, Inc.INKTLIVE ROUTINEARSMiNK Therapeutics, Inc.INKTLIVE ROUTINEDEF 14AMiNK Therapeutics, Inc.INKTLIVE ROUTINE4MiNK Therapeutics, Inc.INKTLIVE John Bradley Holcomb, insider filing for INKT
John Bradley Holcomb, reporting
ROUTINE3MiNK Therapeutics, Inc.INKTLIVE Melissa Orilall, new insider at INKT
Melissa Orilall, reporting
NOTABLE10-KMiNK Therapeutics, Inc.INKTLIVE ROUTINE8-KMiNK Therapeutics, Inc.INKTLIVE ROUTINE8-KMiNK Therapeutics, Inc.INKTLIVE ROUTINE3MiNK Therapeutics, Inc.INKTLIVE Austin Charette, new insider at INKT
Austin Charette, reporting
ROUTINE8-KMiNK Therapeutics, Inc.INKTLIVE ROUTINE4MiNK Therapeutics, Inc.INKTLIVE Barbara Ryan, insider filing for INKT
Barbara Ryan, reporting
ROUTINE4MiNK Therapeutics, Inc.INKTLIVE Barbara Ryan, insider filing for INKT
Barbara Ryan, reporting
ROUTINE4/AMiNK Therapeutics, Inc.INKTLIVE Jennifer Buell, insider filing for INKT (amended)
Jennifer Buell, reporting
ROUTINE4MiNK Therapeutics, Inc.INKTLIVE 5 insider filings
Jennifer Buell, insider filing for INKT
Show all 5
- 4Insider filing for INKT
- 4Insider filing for INKT
- 4Insider filing for INKT
- 4Insider filing for INKT
- 4Insider filing for INKT
Jennifer Buell, reporting
ROUTINE8-KMiNK Therapeutics, Inc.INKTLIVE ROUTINEEFFECTMiNK Therapeutics, Inc.INKTLIVE ROUTINES-3/AMiNK Therapeutics, Inc.INKTLIVE ROUTINE8-KMiNK Therapeutics, Inc.INKTLIVE ROUTINE4MiNK Therapeutics, Inc.INKTLIVE 6 insider filings
Ulf Wiinberg, insider filing for INKT
Show all 6
- 4Insider filing for INKT
- 4Insider filing for INKT
- 4Insider filing for INKT
- 4Insider filing for INKT
- 4Insider filing for INKT
- 4Insider filing for INKT
Ulf Wiinberg, reporting
ROUTINES-3MiNK Therapeutics, Inc.INKTLIVE